Cite
HARVARD Citation
An, Y. et al. (n.d.). P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort. Journal of Crohn's and colitis. pp. i793-i794. [Online].